Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2001

View Archived Issues

Therapeutic efficacy of 6R-BH4 in autism

Shire highlights Q3 developments and updates product pipeline

Supratek initiates enrollment for SP-1049C phase II trial

Research collaboration targets proteins related to muscular dystrophy and neurodegenerative diseases

NicVAX nicotine vaccine completes preclinical safety testing

Investigational cancer drug GS-7836 moves to phase I testing

Development of SMART antibody for Crohn's disease continues based on preliminary findings

E.U. approval of Protopic recommended by CPMP

Launch of Xalcom/Xalacom begins in Europe

PhotoCure reports preliminary results from phase III trial of Metvix in basal cell carcinoma

AASLD news: Ceplene-containing combination therapies effective in hepatitis C

Adolor highlights Q3 clinical trial progress

Sustained antiviral effect, good safety of Coviracil in chronic HBV seen in 48-week phase I trial

Novuspharma updates R&D activities

Research and clinical programs continue to advance at Photogen

Clevudine exerts potent anti-HBV activity in early clinical trial

CTLA4Ig and LEA29Y demonstrate clinical and biological activity in RA

Major approval obtained by Pharmacia/Pfizer for new antiinflammatory/analgesic

Pexelizumab advances to pivotal trials in CABG/CPB patients; phase IIb data discussed at AHA

Antisense compounds designed at Isis targeting the ADAM10 gene

DNA encoding human acid-sensing ion channel cloned and characterized at Ortho-McNeil

Japan Tobacco claims new compounds potentiating neurite outgrowth

Novel series in development by Merck and Banyu has potential for diabetes, obesity, etc.

Inhibitors of P-450RAI as an approach to psoriasis and other retinoid-responsive disorders

P&G patents new MMP inhibitors useful for rheumatoid arthritis, osteoarthritis and cancer

Japanese lab presents new Rho kinase-inhibitory amides

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...